Newfound Research’s Steris STE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$72K Sell
435
-26
-6% -$5.29K 0.18% 84
2022
Q2
$95K Sell
461
-203
-31% -$45.8K 0.2% 46
2022
Q1
$161K Buy
664
+15
+2% +$3.48K 0.21% 28
2021
Q4
$158K Buy
649
+107
+20% +$24.4K 0.19% 35
2021
Q3
$111K Buy
542
+108
+25% +$23.1K 0.18% 47
2021
Q2
$90K Buy
434
+26
+6% +$5.24K 0.18% 36
2021
Q1
$78K Sell
408
-279
-41% -$51.8K 0.18% 53
2020
Q4
$130K Buy
687
+539
+364% +$101K 0.33% 30
2020
Q3
$26K Buy
+148
New +$23.7K 0.07% 105

Other funds holding STE

Newfound Research's STE Position: Q3 2022 in Review

Newfound Research reduced its Steris (STE) stake by 5.6% in Q3 2022, selling an estimated $5.29K and leaving 435 shares worth $72K. The position accounts for 0.18% of the portfolio, ranked #84.

Newfound Research first reported a position in STE in Q3 2020 and has held it in 9 quarters since. The position peaked at $161K in Q1 2022. 637 funds tracked by Wall St. Rank hold STE as of Q3 2022.

  • Newfound Research held 435 shares of Steris worth $72K as of Q3 2022.
  • Newfound Research sold 26 Steris shares in Q3 2022, an estimated $5.29K.
  • Steris made up 0.18% of Newfound Research's portfolio in Q3 2022, its #84 holding.
  • Newfound Research first reported a position in Steris in Q3 2020 and has held it in 9 quarters since.
  • Newfound Research's Steris position peaked at $161K in Q1 2022.
  • 637 funds tracked by Wall St. Rank held Steris as of Q3 2022.

Based on Newfound Research's 13F filing for Q3 2022, filed 13 Oct 2022.